As the criteria for substances to qualify as an endocrine disruptor for human health or the environment included in sections 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009 of the European Parliament and of the Council [Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009, p. 1).] and in Commission Delegated Regulation (EU) 2017/2100 [Commission Delegated Regulation (EU) 2017/2100 of 4 September 2017 setting out scientific criteria for the determination of endocrine-disrupting properties pursuant to Regulation (EU) No 528/2012 of the European Parliament and Council (OJ L 301, 17.11.2017, p. 1).], and those to qualify as an endocrine disruptor for human health or the environment included in Annex I to Regulation (EC) No 1272/2008, are equivalent, substances which qualify as meeting the criteria for endocrine disruptor properties in accordance with Commission Regulation (EU) 2018/605 [Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine-disrupting properties (OJ L 101, 20.4.2018, p. 33).] and Delegated Regulation (EU) 2017/2100 should be included in ‘endocrine disruption for human health category 1’ or ‘endocrine disruption for the environment category 1’ in Table 3 in Part 3 of Annex VI to Regulation (EC) No 1272/2008.
Recital 25, Regulation (EU) 2024/2865
In forcesince 23 Oct 2024
Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 Decembe…Law
Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October…Law
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…Law
- celex=31979L0117
- celex=31991L0414
- num:eu=1979/117
- num:eu=1991/414